{"id":9515,"date":"2025-03-28T16:47:20","date_gmt":"2025-03-28T15:47:20","guid":{"rendered":"https:\/\/aliber.org\/web\/?p=9515"},"modified":"2025-03-28T16:48:20","modified_gmt":"2025-03-28T15:48:20","slug":"aelip-comparte-31-de-marzo-dia-mundial-de-las-lipodistrofias-31m","status":"publish","type":"post","link":"https:\/\/aliber.org\/web\/2025\/03\/28\/aelip-comparte-31-de-marzo-dia-mundial-de-las-lipodistrofias-31m\/","title":{"rendered":"AELIP comparte: 31 DE MARZO DIA MUNDIAL DE LAS LIPODISTROFIAS 31M"},"content":{"rendered":"

EL D\u00cdA MUNDIAL DE LAS LIPODISTROFIAS<\/p>\n

Surge como plataforma para poder desarrollar actividades de referencia, as\u00ed como para emprender, cohesionar e impulsar acciones pol\u00edticas y sociales en distintos lugares de Espa\u00f1a, y Europa, en colaboraci\u00f3n con las alianzas de pa\u00edses iberoamericanos (ALIBER) y la organizaci\u00f3n europea de enfermedades raras ( EURORDIS).<\/p>\n

El primer d\u00eda mundial de las lipodistrofias se celebr\u00f3 en el a\u00f1o 2013 AELIP celebra a nivel internacional en marzo, la Campa\u00f1a de sensibilizaci\u00f3n m\u00e1s importante del a\u00f1o: el D\u00eda Mundial de las Lipodistrofias 31 de marzo.<\/p>\n

Esta campa\u00f1a es impulsada por la Organizaci\u00f3n Europea de Enfermedades Raras (EURORDIS) por la<\/p>\n

Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras (FEDER) y se desarrolla en coordinaci\u00f3n con la Alianza<\/p>\n

Iberoamericana de Enfermedades poco frecuentes (ALIBER) Rare Diseases International (RDI), Sociedad espa\u00f1ola de lipodistrofias (SEL) y el Consorcio Europeo<\/p>\n

\"\"<\/p>\n

 <\/p>\n

 <\/p>\nINFOGRAFIA DIA MUNDIAL 2025<\/a>de Lipodistrofias (ECLIP)<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

EL D\u00cdA MUNDIAL DE LAS LIPODISTROFIAS Surge como plataforma para poder desarrollar actividades de referencia, as\u00ed como para emprender, cohesionar e impulsar acciones pol\u00edticas y sociales en distintos lugares de[…]<\/a><\/p>\n","protected":false},"author":1,"featured_media":9517,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[138,7],"tags":[],"class_list":["post-9515","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","category-socios"],"_links":{"self":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/9515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/comments?post=9515"}],"version-history":[{"count":2,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/9515\/revisions"}],"predecessor-version":[{"id":9519,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/9515\/revisions\/9519"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media\/9517"}],"wp:attachment":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media?parent=9515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/categories?post=9515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/tags?post=9515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}